| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | SetPoint Medical | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $302.51M | Series D | 10/28/2025 | $115.5M | $471.52M | $1.51 | Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest Venture Partners, New Enterprise Associates, Viking Global Investors, Action Potential Venture Capital, Abbott, Boston Scientific, Euclidean Capital, Richard King Mellon Foundation, Morgenthaler Ventures, ShangBay Capital, Ascendum Capital, Catalio Capital Management, Gilmartin Capital, Midas Capital | ||||
 | Slope | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $77.46M | Series A-3 | 7/17/2024 | $45M | $189.34M | $7.73 | Union Square Ventures, Sam Altman, J.P. Morgan, Notable Capital, Y Combinator, Saga Ventures, Across Capital, Citius, Monashees, Stanley Tang, Arash Ferdowsi, Zach Perret, William Hockey, David Helgason, Alex Bouaziz, Avra, FJ Labs, Fjor, Hacklegacy, Kenneth Stone, Michael Tannenbaum, Rujul Zaparde, Mathilde Collin | ||||
 | Snappy | Consumer & Lifestyle E-commerce Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $435.17M | Series D | 4/15/2024 | $35.37M | $219.43M | $2.95 | Qumra Capital, 83North, Saban Ventures, Notable Capital, Hearst Ventures | ||||
 | Spinogenix | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $24.4M | Series D | 11/21/2025 | $9.8M | $365.97M | $34.92 | Undisclosed Investors | ||||
 | SpotHero | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $118.5M | Series D-1 | 8/22/2019 | $47.4M | $292.96M | $4.53 | Macquarie Capital, Union Grove Venture Partners, Insight Venture Partners, Global Founders Capital, OCA Ventures, AutoTech Ventures | ||||
 | Sprinter Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $125.81M | Series B | 5/15/2025 | $55M | $405.27M | $13.95 | General Catalyst, Andreessen Horowitz, Regents of the University of California, GV, Accel | ||||
 | StarTree | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $75.21M | Series B NV | 8/29/2022 | $3.63M | $425.91M | $1.89 | GGV Capital, CRV, Bain Capital, Sapphire Ventures | ||||
 | Straiker | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $84.89M | Series A | 6/29/2026 | $50.34M | $309.82M | $6.07 | Marathon Management Partners, Citi Ventures, Illuminate Financial, Workday Ventures, Bain Capital Ventures, Lightspeed Venture Partners, GTM Capital, Rain Capital, NEVA SGR, Firebolt Ventures, Sixty Degree Capital | ||||
 | Swift Navigation | Consumer & Lifestyle Consumer Electronics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $251.7M | Series E-1 | 7/23/2025 | $33.33M | $213.75M | $1.35 | New Enterprise Associates, Eclipse Ventures, EPIQ Capital Group, First Round Capital, TELUS Global Ventures, Potentum Partners, Niterra Ventures, AlTi Tiedemann Global, GRIDS Capital, Essentia Ventures, Shea Ventures, EnerTech Capital | ||||
 | Synthekine | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $396.11M | Series D | 10/20/2025 | $107.5M | $271.61M | $0.97 | Undisclosed Investors | ||||
 | Tabs | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $85.95M | Series B-1 | 9/16/2025 | $44.7M | $403.19M | $7.85 | General Catalyst, Lightspeed Venture Partners, Primary Venture Partners, WiL | ||||
 | Tamr | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $21M | Series A-2 | 10/14/2026 | $21M | $51.69M | $0.01 | Volition Capital | ||||
 | Torch | Education Other Education | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $80.06M | Series C | 5/23/2022 | $40M | $324.25M | $10.67 | 137 Ventures, Initialized Capital, Norwest Venture Partners, Obvious Ventures | ||||
 | Two Chairs | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $106.66K | -- | 1 | Not available | -- | -- | $92.39M | Series C | 4/16/2024 | $40M | $250.37M | $8.00 | Amplo, Fifth Down Capital | ||||
 | Vedanta Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $126.86M | Series B-1 | 8/6/2026 | $22.57M | $113.87M | $0.17 | AMR Action Fund, BNP Paribas | ||||
 | Verdagy | Energy Clean Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $98.25M | Series B Prime | 8/8/2023 | $36.62M | $348.66M | $21.05 | Temasek, Shell Ventures, Bidra Innovation Ventures, BlueScope, Galp, Samsung Venture Investment, Toppan Ventures, Tupras Venures, Yara Growth Ventures, Zeon Ventures | ||||
 | Virtual Incision | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $157.09M | Series B | 9/17/2026 | $80.14M | $103.13M | $0.13 | Undisclosed Investors | ||||
 | VuMedi | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $80.12M | Series B | 5/14/2025 | $79.98M | $495.24M | $2.11 | Undisclosed Investors | ||||
 | Wag! | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $78.42M | Series P | 1/28/2022 | $11M | $319.43M | $10.00 | Undisclosed Investors | ||||
 | Wander | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $112.1M | Series B | 7/1/2026 | $64.1M | $274.1M | $3.96 | QED Investors, Fifth Wall, Redpoint, Uncork Capital, Starwood Capital Group, Breyer Capital, Authentic Ventures, Activant Capital, Hakluyt Capital, SOMA Capital, Alumni Ventures, Forecast Labs | ||||
 | Zest AI | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $186.63M | Series F-1 | 11/2/2022 | $50.61M | $276.92M | $2.36 | Insight Partners, CMFG Ventures, CU Direct, Curql, Suncoast Credit Union, Golden1Credit Union, Hawaii USA Federal Credit Union, NorthGate Capital | ||||
 | 1047 Games | Consumer & Lifestyle Gaming | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Series X | 4/7/2026 | $0.12 | $4.57M | $0.12 | Undisclosed Investors | ||||
 | Aardvark Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $129.13M | Series C | 5/9/2024 | $85M | $267.58M | $1.77 | Decheng Capital, Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial Group, Walleye Capital, Laurion Capital Management, LG Technology Ventures, Cantor Ventures, Silver Arc Private Capital, Prader-Willi Syndrome Association, Vickers Venture Partners, Foundation for Prader-Willi Research | ||||
 | Akido | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $106.75M | Series B | 5/15/2025 | $60M | $373.15M | $13.45 | Oak HC/FT, Greco, SNR, Y Combinator, Future Communities Capital, Jeff Dean, Comprehensive Blood & Cancer Center | ||||